On the search for in vitro in vivo correlations in the field of intra-articular drug delivery: Administration of sodium diatrizoate to the horse

European Journal of Pharmaceutical Sciences

Volumn 41, Issue 1, 2010, Pages 10-15

  Frost, Anna Buus ^a   Larsen, Frank ^b   Østergaard, Jesper ^a   Larsen, Susan Weng ^a   Lindegaard, Casper ^c   Hansen, Helle Rüsz ^a   Larsen, Claus ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b H LUNDBECK A S   (Denmark)

^c UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

In vitro in vivo correlations; In vitro in vivo relations; Intra articular administration; Osteoarthritis; Pharmacokinetics

Indexed keywords

DIATRIZOATE;

ANIMAL EXPERIMENT; ARTICLE; COMPARTMENT MODEL; CONTROLLED STUDY; CORRELATIONAL STUDY; DIALYSIS; DRUG ABSORPTION; DRUG BIOAVAILABILITY; DRUG DELIVERY SYSTEM; DRUG ELIMINATION; HORSE; IN VITRO STUDY; IN VIVO STUDY; INTRAARTICULAR DRUG ADMINISTRATION; NONHUMAN; PRIORITY JOURNAL; SYNOVIAL FLUID; ANIMAL; ARTICULAR CARTILAGE; DRUG ADMINISTRATION ROUTE;

ANIMALS; CARTILAGE, ARTICULAR; DIATRIZOATE; DRUG ADMINISTRATION ROUTES; HORSES; IN VITRO TECHNIQUES;

EID: 77954760526     PISSN: 09280987     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejps.2010.05.006     Document Type: Article

References (32)

1. Abramson S. Drug delivery in degenerative joint disease: where we are and where to go?. Adv. Drug Deliv. Rev. 2006, 58:125-127.
2. Aigner T., Sachse A., Gebhard P.M., Roach H.I. Osteoarthritis: pathobiology-targets and ways for therapeutic intervention. Adv. Drug Deliv. Rev. 2006, 58:128-149.
3. Baker C.L., Ferguson C.M. Future treatment of osteoarthritis. Orthopedics 2005, 28:S227-S234.
4. Brindley C. Practical deconvolution. Pharmacokinetics in Drug Development: Clinical Study Design and Analysis 2009, vol. 1:479-499. AAPS Press, Arlington.
5. Burgess D.J., Hussain A.S., Ingallinera T.S., Chen M.L. Assuring quality and performance of sustained and controlled release parenterals: workshop report. AAPS PharmSci. 2002, 4:E7.
6. Burgess D.J., Crommelin D.J.A., Hussain A.S., Chen M.L. Assuring quality and performance of sustained and controlled released parenterals. Eur. J. Pharm. Sci. 2004, 21:679-690.
7. Butoescu N., Jordan O., Doelker E. Intra-articular drug delivery systems for the treatment of rheumatic diseases: a review of the factors influencing their performance. Eur. J. Pharm. Biopharm. 2009, 73:205-218.
8. Dibbern H.W., Wirbitzki E. Alternative technique for the determination of drug release from hydrophobic matrix particularly suppositories. Pharm. Ind. 1983, 45:985-990.
9. Evans C.H. Novel biological approaches to the intra-articular treatment of osteoarthritis. Biodrugs 2005, 19:355-362.
10. Frost A.B., Larsen F., Larsen S.W., Østergaard J., Thomsen M.H., Stürup S., Andersen P.H., Larsen C. The pharmacokinetics of the weakly protein-bound anionic compound diatrizoate in serum and synovial fluid of the horse. Pharm. Res. 2009, 27:143-150.
11. Langenbucher F. Numerical convolution deconvolution as a tool for correlating in vitro with in vivo drug availability. Pharm. Ind. 1982, 44:1166-1172.
12. Langenbucher F., Moller H. Correlation of in vitro drug release with in vivo response kinetics. 1. Mathematical treatment of time functions. Pharm. Ind. 1983, 45:623-628.
13. Larsen D.B., Joergensen S., Olsen N.V., Hansen S.H., Larsen C. In vivo release of bupivacaine from subcutaneously administered oily solution. Comparison with in vitro release. J. Control. Release 2002, 81:145-154.
14. Larsen S.W., Østergaard J., Friberg-Johansen H., Jessen M.N.B., Larsen C. In vitro assessment of drug release rates from oil depot formulations intended for intra-articular administration. Eur. J. Pharm. Sci. 2006, 29:348-354.
15. Larsen C., Østergaard J., Larsen S.W., Jensen H., Jacobsen S., Lindegaard C., Andersen P.H. Intra-articular depot formulation principles: role in the management of postoperative pain and arthritic disorders. J. Pharm. Sci. 2008, 97:4622-4654.
16. Larsen S.W., Frost A.B., Østergaard J., Marcher H., Larsen C. On the mechanism of drug release from oil suspensions in vitro using local anesthetics as model drug compounds. Eur. J. Pharm. Sci. 2008, 34:37-44.
17. Lerner H.H. Diatrizoic acid. Analytical Profiles of Drug Substances 1975, 137-167. Academic Press, New York. K. Florey (Ed.).
18. Levitt D.G. The use of a physiologically based pharmacokinetic model to evaluate deconvolution measurements of systemic absorption. BMC Clin. Pharmacol. 2003, 3:1.
19. Levy G. Effect of dosage form on drug absorption frequent variable in clinical pharmacology. Arch. Int. Pharmacodyn. Ther. 1964, 152:59-68.
20. Levy G., Hollister L.E. Inter-+intrasubject variations in drug absorption kinetics. J. Pharm. Sci. 1964, 53:1446-1452.
21. Martinez M., Rathbone M., Burgess D., Huynh M. In vitro and in vivo considerations associated with parenteral sustained release products: a review based upon information presented and points expressed at the 2007 Controlled Release Society Annual Meeting. J. Control. Release 2008, 129:79-87.
22. Nelder J.A., Mead M. A simplex-method for function minimization. Comp. J. 1965, 7:308-313.
23. Pedersen P.V. Model-independent method of analyzing input in linear pharmacokinetic systems having polyexponential impulse response. I: theoretical analysis. J. Pharm. Sci. 1980, 69:298-305.
24. Pedersen B.T., Østergaard J., Larsen S.W., Larsen C. Characterization of the rotating dialysis cell as an in vitro model potentially useful for simulation of the pharmacokinetic fate of intra-articularly administered drugs. Eur. J. Pharm. Sci. 2005, 25:73-79.
25. Schliecker G., Schmidt C., Fuchs S., Ehinger A., Sandow E., Kissel T. In vitro and in vivo correlation of buserelin release from biodegradable implants using statistical moment analysis. J. Control. Release 2004, 94:25-37.
26. Simkin P.A., Bassett J.E., Koh F.M. Synovial perfusion in the human knee-a methodologic analysis. Semin. Arthritis Rheum. 1995, 25:56-66.
27. Steinmeyer J., Konttinen Y.T. Oral treatment options for degenerative joint disease-presence and future. Adv. Drug Deliv. Rev. 2006, 58:168-211.
28. U.S. Department of Health and Human Services, 1997. Guidance for industry. Extended release oral dosage forms: Development, evaluation, and application of in vitro/in vivo correlations.
29. Uppoor V.R.S. Regulatory perspectives on in vitro (dissolution)/in vivo (bioavailability) correlations. J. Control. Release 2001, 72:127-132.
30. Wieland H.A., Michaelis M., Kirschbaum B.J., Rudolphi K.A. Osteoarthritis-an untreatable disease?. Nat. Rev. Drug Discov. 2005, 4:331-344.
31. Yamaoka K., Nakagawa T., Uno T. Application of Akaikes information criterion (AIC) in evaluation of linear pharmacokinetic equations. J. Pharmacokinet. Biopharm. 1978, 6:165-175.
32. Young D., Farrell C., Shepard T. In vitro/in vivo correlation for modified release injectable drug delivery systems. Injectable Dispersed Systems. Formulation, Processing and Performance 2005, 159-176. Taylor & Francis Group, New York. D.J. Burgess (Ed.).